EaveTubes for Vector Control - Trial NCT05736679
Access comprehensive clinical trial information for NCT05736679 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Notre Dame and is currently Not yet recruiting. The study focuses on Malaria. Target enrollment is 1870 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Notre Dame
Timeline & Enrollment
N/A
Jul 01, 2023
Jun 01, 2025
Primary Outcome
Incidence rate of malaria infection
Summary
The goal of this clinical trial is to test whether In2Care EaveTubes (ETs) as a stand-alone
 tool can reduce malaria in an area where transmission is driven by insecticide-resistant
 Anopheles gambiae. Children who live in homes with ETs will be monitored for malaria
 infection and compared to children living in homes without ETs in Côte d'Ivoire where there
 is universal coverage of long lasting insecticide nets and pyrethroid resistance is high.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05736679
Device Trial